ALYSSA KRIEGER: Open Payments
NPI 1568019032 · WAYLAND, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 31 payments from 8 companies in 2025. Trend: 2023 $573 · 2024 $351 · 2025 $686
Food & beverage: $521Education: $165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $220 |
| Regeneron Healthcare Solutions, Inc. | 8 | $146 |
| Janssen Biotech, Inc. | 4 | $139 |
| UCB, Inc. | 2 | $60 |
| GENZYME CORPORATION | 2 | $49 |
| Lilly USA, LLC | 2 | $44 |
| STRATA Skin Sciences, Inc. | 1 | $15 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Bimzelx, TALTZ, XTRAC, NEMLUVIO.
Industry payments across MA — which companies pay providers there.
